Resources & Products

AHRA White Paper Library

Dermal or Not? The Surprising Question We Find Ourselves Asking in Digital Breast Tomosynthesis

While DBT, in some cases, can clearly define a superficial finding as a benign dermal entity, there are instances where superficial lesions initially favored to be dermal are conclusively localized as intraparenchymal during diagnostic evaluation. Cancers can be superficial in location, supporting the continued use of mole markers on DBT.

Disclaimer: The white paper sponsor may contact you but will not share the information you submit in the form.

White Paper